title: Shuganjieyu capsule increases neurotrophic factor expression in a rat model of depression.
abstract: Shuganjieyu capsule has been approved for clinical treatment by the State Food and Drug Ad-ministration of China since 2008. In the clinic, Shuganjieyu capsule is often used to treat mild to moderate depression. In the rat model of depression established in this study, Shuganjieyu capsule was administered intragastrically daily before stress. Behavioral results confirmed that depressive symptoms lessened after treatment with high-dose (150 mg/kg) Shuganjieyu capsule. Immunohistochemistry results showed that high-dose Shuganjieyu capsule significantly increased phosphorylation levels of phosphorylation cyclic adenosine monophosphate response element binding protein and brain-derived neurotrophic factor expression in the medial prefrontal cortex and hippocampal CA3 area. Overall, our results suggest that in rats, Shuganjieyu capsule effec-tively reverses depressive-like behaviors by increasing expression levels of neurotrophic factors in the brain.
authors.affiliation: Mental Health Institute of the Second Xiangya Hospital, Key Laboratory of Psychiatry and Mental Health of Hunan Province, Central South University, Changsha, Hunan Province, China ; Department of Psychiatry, Brain Hospital of Hunan Province, Changsha, Hunan Province, China.
authors.forename: Jinhua
authors.initials: J
authors.lastname: Fu
authors.affiliation: Laboratory of Ethnopharmacology, Institute of Integrated Traditional Medicine and Western Medicine, the Second Xiangya Hospital, Central South University, Changsha, Hunan Province, China.
authors.forename: Yingjin
authors.initials: Y
authors.lastname: Zhang
authors.affiliation: Mental Health Institute of the Second Xiangya Hospital, Key Laboratory of Psychiatry and Mental Health of Hunan Province, Central South University, Changsha, Hunan Province, China.
authors.forename: Renrong
authors.initials: R
authors.lastname: Wu
authors.affiliation: Guangzhou Brain Hospital, Affiliated Hospital of Guangzhou Medical College, Guangzhou, Guangdong Province, China.
authors.forename: Yingjun
authors.initials: Y
authors.lastname: Zheng
authors.affiliation: Mental Health Institute of the Second Xiangya Hospital, Key Laboratory of Psychiatry and Mental Health of Hunan Province, Central South University, Changsha, Hunan Province, China.
authors.forename: Xianghui
authors.initials: X
authors.lastname: Zhang
authors.affiliation: Department of Psychiatry, Brain Hospital of Hunan Province, Changsha, Hunan Province, China.
authors.forename: Mei
authors.initials: M
authors.lastname: Yang
authors.affiliation: Mental Health Institute of the Second Xiangya Hospital, Key Laboratory of Psychiatry and Mental Health of Hunan Province, Central South University, Changsha, Hunan Province, China.
authors.forename: Jingping
authors.initials: J
authors.lastname: Zhao
authors.affiliation: Mental Health Institute of the Second Xiangya Hospital, Key Laboratory of Psychiatry and Mental Health of Hunan Province, Central South University, Changsha, Hunan Province, China.
authors.forename: Yong
authors.initials: Y
authors.lastname: Liu
keywords: NSFC grant; Shuganjieyu capsule; brain-derived neurotrophic factor; chronic unpredictable mild stress; depression; nerve regeneration; neural regeneration; neurotrophic factor; phosphorylation cyclic adenosine monophosphate response element binding protein